Increasing Levels of Serum Anti-Spike S1-RBD IgG after 120 Days of the Pfizer-BioNTech-mRNA Second Dose Vaccination.

Abdul-Wahab Kadhum, A; Rushdi Abdullah, A; Mujahid, A

Abdul-Wahab Kadhum, A; Rushdi Abdullah, A; Mujahid, A.

Afiliación

Abdul-Wahab Kadhum A; Medical Microbiology Department, Medical College, AL-Iraqia University, Baghdad, Iraq.
Rushdi Abdullah A; Medical Microbiology Department, Medical College, AL-Iraqia University, Baghdad, Iraq.
Mujahid A; Medical Microbiology Department, Medical College, AL-Nahrain University, Baghdad, Iraq.

Arch Razi Inst ; 78(3): 1071-1075, 2023 06.

Article en En | MEDLINE | ID: mdl-38028836

Asunto(s)

COVID-19; Vacunas; Humanos; Femenino; Masculino; Adulto; COVID-19/prevención & control; SARS-CoV-2; Anticuerpos Antivirales; Inmunoglobulina G; ARN Mensajero

Palabras clave

Al-Iraqi University; Medical students; Pfizer-BioNTech vaccine; SARS-COVID-19 Anti-Spike IgG

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Adult / Female / Humans / Male Idioma: En Revista: Arch Razi Inst Año: 2023 Tipo del documento: Article País de afiliación: Irak Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google